Cargando…
Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
SUMMARY: Mifepristone is a promising option for the management of hypercortisolism associated with hyperglycemia. However, its use may result in serious electrolyte imbalances, especially during dose escalation. In our patient with adrenocorticotropic hormone-independent macro-nodular adrenal hyperp...
Autores principales: | Sai, Katta, Lal, Amos, Lakshmi Maradana, Jhansi, Velamala, Pruthvi Raj, Nitin, Trivedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865352/ https://www.ncbi.nlm.nih.gov/pubmed/31743097 http://dx.doi.org/10.1530/EDM-19-0064 |
Ejemplares similares
-
Reversible alterations in cardiac morphology and functions in a patient with Cushing's syndrome
por: Iwasaki, Hiroaki
Publicado: (2014) -
Fluticasone furoate induced iatrogenic Cushing syndrome in a pediatric patient receiving anti-retroviral therapy
por: van den Berg, S A A, et al.
Publicado: (2017) -
Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone
por: Dow, Adrienne, et al.
Publicado: (2013) -
Vandetanib induces a marked anti-tumor effect and amelioration of ectopic
Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016) -
Mixed Corticomedullary Tumor of the Adrenal Gland: A Case Report and Literature Review
por: Maradana, Jhansi, et al.
Publicado: (2023)